Tejara Capital LTD Vincerx Pharma, Inc. Transaction History

Tejara Capital LTD

  • $210 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$0.88 - $1.9 $50,629 - $109,314
-57,534 Reduced 19.78%
233,348 $303 Million
Q1 2023

May 12, 2023
SELL
$0.9 - $1.51 $18,000 - $30,200
-20,000 Reduced 6.43%
290,882 $303 Million
Q4 2022

Feb 13, 2023
BUY
$0.64 - $1.32 $198,964 - $410,364
310,882 New
310,882 $317 Million

Others Institutions Holding VINC

# of Institutions
28
Shares Held
11M
Call Options Held
0
Put Options Held
0
View Full List

About Vincerx Pharma, Inc.

VINC Quotes by TradingView
  • Ticker VINC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,189,800
  • Market Cap $6.57M
  • Description
  • Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...
More about VINC
Track This Portfolio

Track Tejara Capital LTD Portfolio

Follow Tejara Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tejara Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email